Dova Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference

World News: . []

DURHAM, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced that Dr. David Zaccardelli, President and Chief Executive Officer, will present a company overview at the Jefferies 2019 Global Healthcare Conference on Tuesday, June 4, 2019 at 11:00 a.m. ET in New York, NY. 

A live audio webcast of the event will be available via the "Investor Relations" page of the Dova website, . Please log on through Dova's website approximately 10 minutes before the scheduled start time. A replay of the webcast will be archived on Dova's website for 90 days following the call.

Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia. Dova’s proprietary pipeline includes one commercial product, DOPTELET, for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure.

Mark W. Hahn (919) 338-7936

Westwicke John Woolford (443) 213-0506

More news and information about Dova Pharmaceuticals, Inc.

Published By:

Globe Newswire: 21:30 GMT Tuesday 28th May 2019

Published: .

Search for other references to "dova" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us